2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theBreast Cancer Liquid Biopsy Market?

The rising incidence of breast cancer is expected to drive the growth of the breast cancer liquid biopsy market in the future. Breast cancer develops in the cells of the breast, typically in the lobules or ducts. The increasing number of breast cancer cases is attributed to factors such as genetic predisposition, hormonal imbalances, aging, lifestyle changes, obesity, alcohol consumption, physical inactivity, radiation exposure, and environmental pollutants. A liquid biopsy is used to detect circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) in the blood, helping monitor the disease in real-time. It aids in assessing treatment responses, detecting therapy resistance, and identifying genetic mutations for targeted therapies. For instance, in 2025, the American Cancer Society, a US-based nonprofit, expects new breast cancer cases to rise to 319,750, up from 313,510 in 2024. Therefore, the rising number of breast cancer cases is driving the growth of the breast cancer liquid biopsy market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21119&type=smp

How Has the Breast Cancer Liquid Biopsy Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The breast cancer liquid biopsy market has experienced rapid expansion, forecasted to rise from $0.78 billion in 2024 to $0.90 billion in 2025 at a CAGR of 15.0%. Factors driving past growth include advancements in next-generation sequencing (NGS), the rising prevalence of breast cancer, increasing demand for non-invasive diagnostics, adoption of personalized medicine, and greater funding for cancer research.

The breast cancer liquid biopsy market is predicted to expand rapidly, growing to $1.56 billion by 2029 at a CAGR of 14.7%. This growth is driven by technological advancements in liquid biopsy assays, increased adoption of liquid biopsy for early cancer detection, a rising demand for real-time cancer monitoring, expanding applications in precision oncology, and greater investments in liquid biopsy research. Expected trends include AI integration in biopsy analysis, advancements in single-cell sequencing, the development of multi-omics liquid biopsy platforms, improvements in biopsy sensitivity and specificity, and the increased use of digital PCR for precise mutation detection.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21119

What Are the Latest Innovations Influencing theBreast Cancer Liquid Biopsy Market?

In the breast cancer liquid biopsy market, companies are focusing on developing companion diagnostics to enable personalized treatment. For instance, in January 2023, Guardant Health Inc., a U.S.-based biotechnology company, received FDA approval for its Guardant360 CDx liquid biopsy test as a companion diagnostic for ORSERDU (elacestrant), a treatment for advanced or metastatic breast cancer patients with ESR1 mutations. This approval allows oncologists to use the test for genomic profiling to identify patients who may benefit from the targeted therapy.

Who Are the Major Industry Players Accelerating Growth in theBreast Cancer Liquid Biopsy Market?

Major companies operating in the breast cancer liquid biopsy market are Johnson & Johnson Private Limited, Roche Diagnostics, Merck KGaA, Thermo Fisher Scientific, Siemens Healthineers, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Myriad Genetics Inc., NeoGenomics Laboratories, Guardant Health Inc., Twist Bioscience, Foundation Medicine Inc., Biodesix Inc., Menarini Silicon Biosystems, Datar Cancer Genetics, Abcam plc, OncoDNA SA, Genomic Health Inc., RainDance Technologies, Biocept Inc., Fluxion Biosciences Inc., Angle plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/breast-cancer-liquid-biopsy-global-market-report

Which Primary Segments of the Breast Cancer Liquid Biopsy Market Are Driving Growth and Industry Transformations?

The breast cancer liquid biopsy market covered in this report is segmented –

1) By Product: Consumables, Kits

2) By Biomarkers: Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), Circulating Tumor RNA (ctRNA), Circulating Tumor Cells (CTCs), Cell-free RNA (cfRNA), Other Biomarkers

3) By Application: Early Detection Or Screening, Diagnosis, Other Applications

4) By End Users: Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories

Subsegments:

1) By Consumables: Reagents, Polymerase Chain Reaction (PCR) Assays, Sequencing Panels, Sample Collection Tubes

2) By Kits: DNA-based Liquid Biopsy Kits, RNA-based Liquid Biopsy Kits, Multi-marker Liquid Biopsy Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21119&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theBreast Cancer Liquid Biopsy Market?# Market?

North America was the largest region in the breast cancer liquid biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Breast Cancer Liquid Biopsy Market 2025, By The Business Research Company:

Nanomedicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Sports Medicine Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sports-medicine-global-market-report

Natural Skin Care Products Global Market Report 2025

https://thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: